Skip to content
Cedilla Therapeutics logo — A New Dimension in Precision Oncology

Cedilla Therapeutics

A New Dimension in Precision Oncology

Founded 2018 United States Cambridge, United States 5 employees Series B Total: $138.80M Biotechnology, Health Care +1

General Information

Company Name Cedilla Therapeutics
Founded Year 2018
Location United States Cambridge, United States
Employees 5
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Cedilla Therapeutics. To contact Cedilla Therapeutics, visit cedillatx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cedilla Therapeutics compare?

A PDF of Cedilla Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cedilla Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cedilla Therapeutics

Cedilla Therapeutics, founded in 2018, is redefining precision oncology with its innovative approach. Described as "A New Dimension in Precision Oncology," the company focuses on modulating protein function within cells to selectively inhibit oncogenic drivers. Their conditional inhibitors have successfully targeted elusive cancer drivers such as TEAD and CDK2. With a recent Series B investment of $25.00M led by RA Capital Management, Third Rock Ventures, Janus Handerson, Logos Capital, and Woodline Partners in October 2021, Cedilla continues to gain momentum in the biotechnology and healthcare industries. Headquartered in the United States, the company's patient-focused and determined team is poised to make significant contributions to the field of oncology. This innovative approach and recent investment make Cedilla Therapeutics an exciting prospect for potential investors in the healthcare sector.

Business keywords: Precision oncology, Protein function, Small molecule inhibitors, Cancer targets, TEAD, CDK2, Oncogenic drivers, Protein modulation, Drug discovery, Therapeutics, Patient-focused, Cell biology, Medical research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $25.00M 5
RA Capital Management, Third Rock Ventures +3
25 Oct 2021
Series B $57.60M 5
Casdin Capital, Third Rock Ventures +3
13 Oct 2020
Series A $56.20M -
24 Apr 2018

Cedilla Therapeutics Alternatives & Competitors

View All Alternatives
Cedilla Therapeutics vs
PIC Therapeutics
PIC Therapeutics United States

Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes

Series A
8 employees
Biotechnology, Health Care
Cedilla Therapeutics vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post-IPO Equity
182 employees
Biotechnology, Health Care
Cedilla Therapeutics vs
Incyclix Bio
Incyclix Bio United States

Regaining Cell Cycle Control

Series B
13 employees
Biotechnology, Health Care

FAQ About Cedilla Therapeutics

A New Dimension in Precision Oncology
Cedilla Therapeutics was founded in 2018.
Cedilla Therapeutics is headquartered in Cambridge, United States.
Cedilla Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Precision oncology, Protein function, Small molecule inhibitors and Cancer targets.
Cedilla Therapeutics has approximately 5 employees.
Cedilla Therapeutics has completed 3 funding rounds, raising a total of $138.80M. The latest funding stage is Series B.
Top alternatives and competitors to Cedilla Therapeutics include PIC Therapeutics, Tango Therapeutics, Incyclix Bio, BiPER Therapeutics, Normunity. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cedilla Therapeutics and PIC Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cedilla Therapeutics, https://bouncewatch.com/company/cedilla-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout